Community Acquired PneumoniaNCT01236677
The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing
An observational study of Community Acquired Pneumonia, run by Capital Medical University at 1 site in China.
Trial summary
In the 21st century, threats to human health of new respiratory infectious diseases increased. The project aim is to establish pneumonia pathogens network in Beijing and understand the pathogen spectrum distribution. Read more about this study
- Who is it for?
- Ages 14 to 90 years
- Conditions the study is for
- Community Acquired Pneumonia
- How many people
- 1,100 participants
- Where
- 1 siteChina
- Study dates
- Aug 2010to Dec 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 90 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Confirmed community acquired pneumonia
Who may be able to join
- Confirmed community acquired pneumonia
- Age≥14 ys
- New appear of cough or cough become severe
- New infiltration showed by chest radiology(x-ray or CT)
- Fever T>37.8o C or <35.6o C
- White blood cell>10,000/mm3 , left shift or leukopenia<4000/ul）
Who cannot join
- Pregnancy or breast-feeding
- Over one week after the onset of symptoms
- HIV infection
- Recent 90-day hospitalized history(length of stay greater than 2 days)
- Live in nursing homes or rehabilitation hospitals
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute
Beijing, Beijing Municipality, 100020
Bin Cao, Doctor, 86-010-85231167, caobin1999@gmail.com
About this study
In the 21st century, threats to human health of new respiratory infectious diseases increased.
The project aim is to establish pneumonia pathogens network in Beijing and understand the pathogen spectrum distribution.
- Conditions
- Community Acquired Pneumonia
- Keywords
- Pathogen
- Medical subject headings
- Community-Acquired Pneumonia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Community acquired pneumonia,age≥14 ys | Patients with community acquired pneumonia,age≥14 ys and less than one week after the onset of symptoms, without pregnancy,breast-feeding,HIV infection,recent 90-day hospitalized history and in nursing homes or rehabilitation hospitals |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to resolution of all symptoms (defined as the period from start of study-drug to relief of fever)
Measured: one year
Secondary outcomes (2)
If duration of symptoms long, follow-up 30 days.
Measured: one year
In case of early termination:death;diagnosed tuberculosis;diagnosed lung cancer and HIV infection
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Nov 2010 (estimated)
- Study startAug 2010
- Primary completionDec 2011 (estimated)
- Study completionDec 2011 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Community Acquired PneumoniaStudies of the same condition, open and under way.
- More trials run by Capital Medical UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Capital Medical University
- Sponsor type
- University, hospital or other
- Investigators
- Chen Wang, Doctor, Study chair, Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01236677
- Sponsor's protocol ID
- xfcrb123456
- Status last verified
- Aug 2010
- First submitted
- 8 Nov 2010
- Last updated
- 14 Dec 2010
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 14 Dec 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing
- ClinicalTrials.gov ID
- NCT01236677
- Acronym / sponsor ID
- xfcrb123456
- Conditions
- Community Acquired Pneumonia
- Keywords
- Pathogen
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,100 participants (estimated)
- Lead sponsor
- Capital Medical UniversityUniversity, hospital or other
- Study start
- Aug 2010
- Primary completion
- Dec 2011 (estimated)
- Study completion
- Dec 2011 (estimated)
- First posted
- 9 Nov 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the 21st century, threats to human health of new respiratory infectious diseases increased.
The project aim is to establish pneumonia pathogens network in Beijing and understand the pathogen spectrum distribution.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Community acquired pneumonia,age≥14 ys | – | –Patients with community acquired pneumonia,age≥14 ys and less than one week after the onset of symptoms, without pregnancy,breast-feeding,HIV infection,recent 90-day hospitalized history and in nursing homes or rehabilitation hospitals |
Who may qualify
- Ages
- 14 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Confirmed community acquired pneumonia
Key inclusion criteria (6 listed)
- Confirmed community acquired pneumonia
- Age≥14 ys
- New appear of cough or cough become severe
- New infiltration showed by chest radiology(x-ray or CT)
- Fever T>37.8o C or <35.6o C
Key exclusion criteria (5 listed)
- Pregnancy or breast-feeding
- Over one week after the onset of symptoms
- HIV infection
- Recent 90-day hospitalized history(length of stay greater than 2 days)
- Live in nursing homes or rehabilitation hospitals
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Time to resolution of all symptoms (defined as the period from start of study-drug to relief of fever)
Time frame: one year
2 secondary outcomes
If duration of symptoms long, follow-up 30 days.
Time frame: one year
In case of early termination:death;diagnosed tuberculosis;diagnosed lung cancer and HIV infection
Time frame: one year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Dec 2010.
Related trials for Community Acquired Pneumonia
Not yet recruiting
Expanded Diagnostic Strategy in Older Adults Hospitalized With Community-Acquired Acute Respiratory Infection
Acute Respiratory Infection
RecruitingObservational study
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
Pneumonia, Community-Acquired, COVID-19 Pneumonia
Active, not recruitingPhase 2/3
Local Antibiotic Delivery for Community Acquired Pneumonia
Community Acquired Pneumonia (CAP)
Not yet recruitingPhase 4
Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia
Community Acquired Pneumonia (CAP)
Active, not recruitingPhase 2/3
Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia
Community-acquired Pneumonia, CAP
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chen Wang, Doctor study chair
Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Community Acquired Pneumonia, run by Capital Medical University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Dec 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Bin Cao, Doctor (86-010-85231167, caobin1999@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to resolution of all symptoms (defined as the period from start of study-drug to relief of fever) (time frame: one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2010.